Home
>
National Drug Code (NDC)
>
ENDODAN
ENDODAN - 16590-947-90 - (OXYCODONE and ASPIRIN)
Drug Information of ENDODAN
| Product NDC: | 16590-947 |
| Proprietary Name: | ENDODAN |
| Non Proprietary Name: | OXYCODONE and ASPIRIN |
| Active Ingredient(s): | 325; 4.8355 mg/1; mg/1 & nbsp; OXYCODONE and ASPIRIN |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ENDODAN
| Product NDC: | 16590-947 |
| Labeler Name: | STAT RX USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA007337 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 19940520 |
Package Information of ENDODAN
| Package NDC: | 16590-947-90 |
| Package Description: | 90 TABLET in 1 BOTTLE (16590-947-90) |
NDC Information of ENDODAN
| NDC Code | 16590-947-90 |
| Proprietary Name | ENDODAN |
| Package Description | 90 TABLET in 1 BOTTLE (16590-947-90) |
| Product NDC | 16590-947 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | OXYCODONE and ASPIRIN |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19940520 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | STAT RX USA LLC |
| Substance Name | ASPIRIN; OXYCODONE HYDROCHLORIDE |
| Strength Number | 325; 4.8355 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
